Although the COVID-19 pandemic exposed cybersecurity vulnerabilities across sectors, it has particularly challenged the resilience of information systems for health care and life sciences companies. Because ransomware attacks...more
This Diagnosing Health Care episode looks at the adjustments to business operations and compliance programs that pharmaceutical and medical device companies need to consider as they launch new products during the ongoing...more
9/29/2020
/ Clinical Trials ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Life Sciences ,
Manufacturer Liability ,
Medical Devices ,
Medical Supplies ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Product Development Protocols ,
Research and Development